Mike Adams, the Health Ranger
See article keywords and concepts |
 But what about a company like a big pharmaceutical company? Is it creating anything that’s really enhancing the health and lives of people? I don't think so. In fact, I don't think the pharmaceutical industry can show a single person who is healthier from depending on pharmaceuticals. I haven't seen a single person in my entire life who has been made healthier by depending on pharmaceuticals.
The bottom line is that drugs simply don't make people healthier. All they do is mask symptoms and in doing so they typically create new symptoms that have to be masked by yet another drug. |
| If you invest in a pharmaceutical company that is selling dangerous products to the public and hiding evidence of those dangers, then you are in fact bankrolling a system that is unleashing untold harm onto the American public. You are bankrolling a system of evil.
It is time, I think, for people to reevaluate their investments in the pharmaceutical industry. It is time to think about the social consequences of where your money goes, because your money isn't just dollars and cents -- it represents time, energy, effort and intention. |
Too Profitable to CureBrent Hoadley, Ph.D.
See book keywords and concepts |
| If a patient suffers because of their product, the pharmaceutical company denies responsibility and redirects blame to the patient or the disease.
Oraflex as an Example
The power and profitability of the pharmaceutical industry is mind-boggling. Consider the money stream generated by a single drug. Five percent of arthritis and chronic pain sufferers will be switched to a "new" and "better" product shortly after it enters the marketplace. Conservatively, 2.5 million people will take this pill every day, producing a $2/ pill profit for the pharmaceutical patent holder. |
Charles Barber
See book keywords and concepts |
 Some academics simply put their names on the articles already produced by the pharmaceutical company, while others work from a draft given to them. A Georgetown University medical professor, Dr. Adriane Fugh-Berman, has documented how she was contacted by RxComms, a British medical communications company, to author a review of interactions between herbs and a generic anticoagulant called warfarin.* "Months later, I received a completed 2,848-word draft, with an abstract, references, and a table, ready for submission to a journal, with my name on it. |
C. W. Randolph, M.D.
See book keywords and concepts |
 Recently, the pharmaceutical company Eli Lilly, a manufacturer of rBST, reported a tenfold increase in IGF-1 levels in the milk of cows that had been injected with the hormone. IGF-1 is the same in humans and cows and is not destroyed by pasteurization. In fact, the pasteurization process actually increases IGF-1 levels in milk.
I recommend that you avoid buying milk from cows treated with rBST, if possible. The hormone has become so widely used by dairy farmers that unless the milk label states "from cows not treated with rBST," you should assume that the milk contains the hormone. |
Craig Pepin-Donat
See book keywords and concepts |
 The way the system actually works is that the FDA's Center for Drug Evaluation and Research either receives information about a problem directly from the pharmaceutical company that developed the drug or they have to rely on a system implemented in 1993 called "The FDA Safety Information and Adverse Event Reporting Program" (MedWatch). This system allows health professionals and the general public to voluntarily report adverse events associated with medical products that fall under FDA jurisdiction. |
Andreas Moritz
See book keywords and concepts |
 Would any pharmaceutical company risk repeating the same experiment, but with different subjects, if this could lead to significantly altered or even contrary results?
It is important to realize that a particular drug or treatment may produce different results in different people and can, therefore, not be considered objectively testable for efficacy. A drug may not work for a particular patient unless he "allows" it to work. |
Dr. Steve Blake
See book keywords and concepts |
 The Most Popular Supplement
The Swiss pharmaceutical company Hoffman-La Roche was the first to mass-produce vitamin C. Today, many thousands of tons of ascorbic acid are produced synthetically from glucose. The glucose is often derived from corn syrup.
Many consumers believe that vitamin C is beneficial, as about 30 percent of the U.S. adult population takes supplemental vitamin C. Currently, vitamin C is the most widely used vitamin supplement in the world.
Vitamin C is also used extensively to preserve food. |
Bill Sardi
See book keywords and concepts |
 But they lament that DCA is unpatentable so it is not likely to receive any attention, or research funding, from a pharmaceutical company.
Now there is the rub. The admission there may be a cure for cancer out there, but it's gotta make a big profit for a drug company or they won't pay attention to it. This is commercially understandable. However, this serves to say, simpler remedies may exist, but patients are going to have to go on a scavenger hunt to find them on their own. |
| In the first instance, the researcher involved in spreading this rumor was being backed by a billion-dollar pharmaceutical company that had a secret project underway to develop a resveratrol-like drug for cancer. If Americans began taking resveratrol dietary supplements on their own, they could likely discover it cures cancer, and this would interfere with their efforts to introduce a resveratrol-like drug.
The other researcher, who was quoted in news reports as saying resveratrol could cause cancer, later had a plausible denial. |
Too Profitable to CureBrent Hoadley, Ph.D.
See book keywords and concepts |
| The pharmaceutical company who manufactured this drug wanted a new money-maker to capitalize on the growing Type 2 diabetes market. The FDA provided fast track approval for the drug in the summer of 1997. In December 1997, British regulatory officials withdrew Rezulin from the market after 6 Rezulin-related deaths were reported.3
However, in the U.S., pharmaceutical representatives promoted the drug to doctors, and doctors prescribed it, without qualms, to their patients. It was the newest, it was the best, and it had FDA approval. |
| Today's "new" scientist is given an answer by the pharmaceutical company, and arranges experimentation in such a manner as to answer the question in the most favorable manner. Exceptions to the results are considered irrelevant. The exceptions can be ignored, manipulated to conform to experimental criteria, or dropped from the trial-base altogether for a multitude of reasons. In other words, results that are contrary to those expected are often weeded out or hidden, never reaching the regulatory authority for evaluation. |
Benjamin H. Natelson, M.D.
See book keywords and concepts |
 When a pharmaceutical company wants to bring a new antidepressant to market, it must definitively show that its product works better than a placebo, a "sugar" pill that has no biological activity. But the drug company does not have to show that its product works better than products already in the market. So doctors have to choose from among many products, but receive surprisingly little information that helps them make their choices. Doctors tend to try new medicines when they are looking for options beyond their usual ones. |
Bill Sardi
See book keywords and concepts |
| The Cancer Care Industry
INTRODUCTION
An army of doctors, pathologists, surgeons, radiologists, nurses, researchers, and pharmaceutical company personnel go to work every day in the war against cancer. They depend upon a steady stream of patients to keep the industry churning dollars rather than cures. This year some 1.4 million Americans will have a frightening diagnosis of cancer and enter a cancer care system that is dysfunctional if not outright fraudulent. |
Bottom Line Health
See book keywords and concepts |
| Right now, a pharmaceutical company can conduct a dozen trials for a new drug.. .only publish the positive-result trials... and then use those as evidence for drug approval or marketing. Drug companies should be required to register every study in a central database and publish all results so that we can judge for ourselves what to allow into our medicine cabinets.
How to Save Hundreds of Dollars Buying Drugs Online
Rick Melcher, RPh, registered pharmacist, Yakima, WA, and coauthor of Smart Buys Drug-Wise. Harbor. www.smartbuysdrugwise.com. |
| When a pharmaceutical company sponsors a study, the odds are five times greater that the findings will favor its product.
Drug and medical industries fund 70% of continuing education lectures and seminars, which are among the activities that doctors are required to attend to maintain their licenses to practice. Wherever doctors turn for sources of information, drug companies dominate.
•Who should be monitoring doctors' relationships with drug companies? |
| The results of this study update do not change what is known about the safety of acetaminophen," says Kathy Fallon, a spokeswoman for pharmaceutical company McNeil. "When taken in recommended doses, acetaminophen is a safe and effective pain reliever."
POSSIBLE SOLUTIONS
The study's authors believe that one way to reduce the number of acetaminophen overdoses is to restrict the package size of OTC acetaminophen and of prescriptions of narcotic-acetamin-ophen combinations. |
Too Profitable to CureBrent Hoadley, Ph.D.
See book keywords and concepts |
| The latter methods are probably a good example of research that a pharmaceutical company would support, since they would result in a "cure" that requires continuous drug treatment.
In any field of study where new ideas are the lifeblood of a guaranteed money stream, the patent literature provides a clue to future successes. |
| Besides receiving funds for academic research, he serves as consultant, owns stock in, and/or is a member of the speaker's bureau for virtually every pharmaceutical company that manufactures drugs for treating mental illness. As a member of the speaker's bureau, he gives talks to other physicians on behalf of the companies who "employ" him. At a minimum, this actively puts patients' rights at a disadvantage.
This interwoven network is pointed out quite well by Paone in "When Big Pharma Courts Academia. |
Bill Sardi
See book keywords and concepts |
| Days those individuals gain with the drug Tarceva
$2,000 Cost in dollars of Tarceva per month
300 Anticipated annual sales in millions of dollars of the drug
6 Percentage rate of increase of stroke in those taking Tarceva
Source: Los Angeles Times
Doctors join in
A scheme between urologists and a pharmaceutical company to sell the anti-hormone drug Lupron, considered the primary treatment for advanced prostate cancer, came into public view recently. Physicians could purchase Lupron at low prices, and in turn were reimbursed at exorbitantly high prices by Medicare. |
Benjamin H. Natelson, M.D.
See book keywords and concepts |
| This depends on the interest of the pharmaceutical company. I am currently testing those waters.
A Device Instead of a Drug
If you think back to the discussions in chapter 7 of the way I treat pain, you will see that treatments for pain often consist of drugs with antidepressant properties and others that treat epilepsy. Although depression and pain can be related, there is no other seeming relation between pain and epilepsy—except for the success of a common group of drugs in both conditions. That is the start of a story about vagal nerve stimulation. |
Mike Adams, the Health Ranger
See article keywords and concepts |
 REPPED: (NewsTarget Editorial) It's no surprise these days to hear about a pharmaceutical company committing scientific fraud and distorting clinical trials to get the results they want, but it's unusual to see it done as blatantly and arrogantly as what you're about to see here.
In June, 2002, Merck and Shering-Plough began a cholesterol study called "ENHANCE" to test the effectiveness of their blockbuster drug Vytorin ($3 billion in sales so far). The trial concluded in 2006, and the final results are still not available. Why? |
Mike Adams, the Health Ranger
See article keywords and concepts |
 I am here to help save lives, not to prop up the shareholder value of some pharmaceutical company."
The full report, Breast Cancer Deception, is available now at: www.NewsTarget.com/Report_Breast_Cancer_Deception_0. |
Mike Adams, the Health Ranger
See article keywords and concepts |
 A provision in the Senate bill that could make it more difficult for patients who are harmed by an unsafe drug to sue the pharmaceutical company also should be removed, CU said.
"To truly protect consumers, the final bill must require accurate, public drug trial results, and it must not interfere in any way with the right of patients to hold drug companies accountable in court when they are harmed by unsafe medications," Vaughan said.
Should the public be informed?
Now what about the question of whether the public should have access to such a database of clinical trial results? |
Mike Adams, the Health Ranger
See article keywords and concepts |
 REPPED: Following the mysterious, accelerating collapse of honeybees across North America and Europe -- a condition dubbed "Colony Collapse Disorder" -- ConPfuzer, a top pharmaceutical company, has announced a new, patented medication designed to treat the disorder by drugging honeybees with psychotropic chemicals. ConPfuzer shares rose $14 in trading today as ConPfuzer's lead pharmaceutical entomologist created quite a buzz with his explanation of how the new drug -- called "Buzzalin" -- might work. "We have discovered that honeybees are suffering from a brain chemistry disorder," said Dr. B. |
Mike Adams, the Health Ranger
See article keywords and concepts |
 Don't you find it curious that the FDA has raided lots of vitamin companies and confiscated countless truckloads of nutritional products, but has never (to my knowledge) conducted an armed raid on a major pharmaceutical company and confiscated the brand-name prescription drugs that are actually killing people?
The truth is, the FDA treats Big Pharma with kid gloves. It even "negotiates" with drug companies to decide on how, and when, and at what size safety warning labels should be printed. |
Charles Barber
See book keywords and concepts |
| An analysis of all clinical trials published in four of the most prestigious psychiatric journals—397 trials—found that 60 percent had received funding from a pharmaceutical company or other interested party. About half of those studies were authored by at least one person with a reported financial conflict of interest. To no one's evident surprise, trials that reported such a conflict of interest were almost five times more likely to find positive results about the drug. |
Mark Sircus
See book keywords and concepts |
 If we look at FluMist, another new nasal vaccine, we see a pharmaceutical company deliberately spilling into the environment contagious influenza viruses.
The FluMist vaccine is a live virus vaccine that is given as a nasal spray. The virus can be shed from the nasal passages of a vaccinated individual for up to 21 days after vaccination. |
Stacy Malkan
See book keywords and concepts |
 After buying up cancer clinics around the country, Zeneca merged with the Swedish pharmaceutical company Astra in 1999 to form AstraZeneca, the world's third largest drug company.
"This is a conflict of interest unparalleled in the history of American medicine," said Dr. Samuel Epstein, a professor of occupational and environmental medicine at the University of Illinois School of Public Health. |
Email this page to a friend
